ADC Therapeutics SA (NYSE:ADCT) Given Consensus Rating of “Hold” by Analysts
Shares of ADC Therapeutics SA (NYSE:ADCT – Get Free Report) have received a consensus rating of “Hold” from the six analysts that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to […]
More Stories
Heritage Insurance Holdings Reports Estimated Catastrophe Losses in 8-K Filing
Heritage Insurance Holdings, Inc. (NYSE:HRTG) released an 8-K filing on October 22, 2024, disclosing estimated catastrophe losses for the quarter...
PepsiCo, Inc. (NASDAQ:PEP) Shares Sold by Heartland Bank & Trust Co
Heartland Bank & Trust Co cut its holdings in PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 2.9% during the third...
Veritone (NASDAQ: VERI) Completes Divestiture and Provides Financial Updates
Veritone, Inc. announced the successful completion of its Divestiture agreement with Oxford Buyer, LLC, an affiliate of Insignia Capital Group...
iShares iBonds Dec 2025 Term Corporate ETF (NYSEARCA:IBDQ) Stock Holdings Boosted by Heartland Bank & Trust Co
Heartland Bank & Trust Co raised its position in shares of iShares iBonds Dec 2025 Term Corporate ETF (NYSEARCA:IBDQ –...
Estée Lauder Companies (NYSE:EL) & PT Unilever Indonesia Tbk (OTCMKTS:UNLRY) Head to Head Analysis
PT Unilever Indonesia Tbk (OTCMKTS:UNLRY – Get Free Report) and Estée Lauder Companies (NYSE:EL – Get Free Report) are both...
McAdam LLC Sells 443 Shares of Vanguard Large-Cap ETF (NYSEARCA:VV)
McAdam LLC cut its holdings in Vanguard Large-Cap ETF (NYSEARCA:VV – Free Report) by 2.9% in the third quarter, according...